Review



anti eaat2 antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc anti eaat2 antibody
    Anti Eaat2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti eaat2 antibody/product/Cell Signaling Technology Inc
    Average 93 stars, based on 27 article reviews
    anti eaat2 antibody - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    Cell Signaling Technology Inc anti eaat2 antibody
    Anti Eaat2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti eaat2 antibody/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    anti eaat2 antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc eaat2 antibody
    a Increased <t>EAAT2</t> protein level in GFAP-NLG3 KO (n = 6 mice) compared to GFAP-NLG3 WT mice (n = 6 mice, p = 0.0494). b , c Increased EAAT2 fluorescence intensity in total hippocampus (top, n = 10 sections, 3 mice, p = 0.00754) and GFAP+ cells (bottom, p = 0.0000453) in GFAP-NLG3 KO (n = 36 cells, 3 mice) compared to GFAP-NLG3 WT (n = 35 cells, 3 mice) mice. d Reduced EAAT2 protein level in GFAP-NLG3 KO mice virally expressing WT NLG3-HA compared to control EGFP (n = 4 mice, p = 0.0265). e , f Increased surface EAAT2 fluorescence intensity in total hippocampus (n = 10 sections, 3 mice, p = 0.0260) and in GFAP+ cells (n = 40 cells from 3 mice, p = 0.00000871) in GFAP-NLG3 KO compared to GFAP-NLG3 WT mice. g , h AAV virus construct, iGluSnFR expression and normalized data ( h ) showing increased iGluSnFR signals in response to social sniffing episodes in GFAP-NLG3 WT (n = 5 recordings, 5 mice), but not in GFAP-NLG3 KO mice (n = 4 recordings, 4 mice). i Reduced iGluSnFR signals after initial social sniffing in GFAP-NLG3 KO mice compared to GFAP-NLG3 WT (n = 5 mice for each genotype, p = 0.0437). Data represent mean ± SEM; two-tailed t test for ( c , d , f and i ); *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 100 μm in left ( b , e ), 10 μm in right ( b and e ); Source data are provided as a Source Data file.
    Eaat2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eaat2 antibody/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    eaat2 antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc eaat2 20848 antibodies
    Figure 6. AptB1 interacting with <t>EAAT2,</t> Nucleolin, and YB-1. (a) Results of AptB1-AP/MS study revealed three candidate AptB1- interacting proteins: EAAT2, YB-1, and Nucleolin. (b) AP-immunoblots verified the interaction between AptB1 and EAAT2, Nucleolin, as well as YB-1 in the PC9 cells and in the mouse brain. (c) The confocal microscopy images showed colocalization (yellow) of AptB1 (red) and Nucleolin (green, upper panel) or YB-1 (green, lower panel) in the PC9 cells. (d) AptB1-treated cells were fractionated into cytosol and nucleus fractions. GAPDH is a cytosolic marker, and Histone H3 is a nucleus marker. The AptB1 sequences were successfully amplified in both cellular fractions. (e) The Coomassie Blue stain and the immunoblots showed the purified GST and GST-YB-1 proteins. (f) The YB-1 exonuclease assay results supported the role of YB-1 as an exonuclease for AptB1. (g) Scheme illustrating the proposed mechanism of AptBCis1 as therapeutics for lung cancer with and without LM.
    Eaat2 20848 Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eaat2 20848 antibodies/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    eaat2 20848 antibodies - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc rabbit anti human eaat2 antibody
    Figure1. PrototypicalcharacteristicsofastrocytesexhibitedbyhumanPDAs.ExpressionofGFAPwasevaluatedbyWesternblot <t>(a)andimmunofluorescence(b),EAAT2/GLT-1(c),andglutamatesynthetase(d)wasevaluatedinPDAsbyWesternblot.GAPDH</t> wasusedasaloadingcontrol.Ine,glutamateuptakeinPDAswasmeasuredusingaglutamateassayfromBioVision(Milpitas,CA) with or without the addition of a GLT-1 inhibitor, DL-TBOA, at 100 M.
    Rabbit Anti Human Eaat2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human eaat2 antibody/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    rabbit anti human eaat2 antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    a Increased EAAT2 protein level in GFAP-NLG3 KO (n = 6 mice) compared to GFAP-NLG3 WT mice (n = 6 mice, p = 0.0494). b , c Increased EAAT2 fluorescence intensity in total hippocampus (top, n = 10 sections, 3 mice, p = 0.00754) and GFAP+ cells (bottom, p = 0.0000453) in GFAP-NLG3 KO (n = 36 cells, 3 mice) compared to GFAP-NLG3 WT (n = 35 cells, 3 mice) mice. d Reduced EAAT2 protein level in GFAP-NLG3 KO mice virally expressing WT NLG3-HA compared to control EGFP (n = 4 mice, p = 0.0265). e , f Increased surface EAAT2 fluorescence intensity in total hippocampus (n = 10 sections, 3 mice, p = 0.0260) and in GFAP+ cells (n = 40 cells from 3 mice, p = 0.00000871) in GFAP-NLG3 KO compared to GFAP-NLG3 WT mice. g , h AAV virus construct, iGluSnFR expression and normalized data ( h ) showing increased iGluSnFR signals in response to social sniffing episodes in GFAP-NLG3 WT (n = 5 recordings, 5 mice), but not in GFAP-NLG3 KO mice (n = 4 recordings, 4 mice). i Reduced iGluSnFR signals after initial social sniffing in GFAP-NLG3 KO mice compared to GFAP-NLG3 WT (n = 5 mice for each genotype, p = 0.0437). Data represent mean ± SEM; two-tailed t test for ( c , d , f and i ); *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 100 μm in left ( b , e ), 10 μm in right ( b and e ); Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Astrocytic neuroligin 3 regulates social memory and synaptic plasticity through adenosine signaling in male mice

    doi: 10.1038/s41467-024-52974-3

    Figure Lengend Snippet: a Increased EAAT2 protein level in GFAP-NLG3 KO (n = 6 mice) compared to GFAP-NLG3 WT mice (n = 6 mice, p = 0.0494). b , c Increased EAAT2 fluorescence intensity in total hippocampus (top, n = 10 sections, 3 mice, p = 0.00754) and GFAP+ cells (bottom, p = 0.0000453) in GFAP-NLG3 KO (n = 36 cells, 3 mice) compared to GFAP-NLG3 WT (n = 35 cells, 3 mice) mice. d Reduced EAAT2 protein level in GFAP-NLG3 KO mice virally expressing WT NLG3-HA compared to control EGFP (n = 4 mice, p = 0.0265). e , f Increased surface EAAT2 fluorescence intensity in total hippocampus (n = 10 sections, 3 mice, p = 0.0260) and in GFAP+ cells (n = 40 cells from 3 mice, p = 0.00000871) in GFAP-NLG3 KO compared to GFAP-NLG3 WT mice. g , h AAV virus construct, iGluSnFR expression and normalized data ( h ) showing increased iGluSnFR signals in response to social sniffing episodes in GFAP-NLG3 WT (n = 5 recordings, 5 mice), but not in GFAP-NLG3 KO mice (n = 4 recordings, 4 mice). i Reduced iGluSnFR signals after initial social sniffing in GFAP-NLG3 KO mice compared to GFAP-NLG3 WT (n = 5 mice for each genotype, p = 0.0437). Data represent mean ± SEM; two-tailed t test for ( c , d , f and i ); *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 100 μm in left ( b , e ), 10 μm in right ( b and e ); Source data are provided as a Source Data file.

    Article Snippet: For surface EAAT2 staining, brain slices were blocked in 10% FBS and incubated with EAAT2 antibody (1:200; Cat# 20848, CST) overnight at 4 °C followed by secondary antibodies, without a prior PBT treatment.

    Techniques: Fluorescence, Expressing, Control, Virus, Construct, Two Tailed Test

    Figure 6. AptB1 interacting with EAAT2, Nucleolin, and YB-1. (a) Results of AptB1-AP/MS study revealed three candidate AptB1- interacting proteins: EAAT2, YB-1, and Nucleolin. (b) AP-immunoblots verified the interaction between AptB1 and EAAT2, Nucleolin, as well as YB-1 in the PC9 cells and in the mouse brain. (c) The confocal microscopy images showed colocalization (yellow) of AptB1 (red) and Nucleolin (green, upper panel) or YB-1 (green, lower panel) in the PC9 cells. (d) AptB1-treated cells were fractionated into cytosol and nucleus fractions. GAPDH is a cytosolic marker, and Histone H3 is a nucleus marker. The AptB1 sequences were successfully amplified in both cellular fractions. (e) The Coomassie Blue stain and the immunoblots showed the purified GST and GST-YB-1 proteins. (f) The YB-1 exonuclease assay results supported the role of YB-1 as an exonuclease for AptB1. (g) Scheme illustrating the proposed mechanism of AptBCis1 as therapeutics for lung cancer with and without LM.

    Journal: ACS nano

    Article Title: AptBCis1, An Aptamer-Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis.

    doi: 10.1021/acsnano.4c04680

    Figure Lengend Snippet: Figure 6. AptB1 interacting with EAAT2, Nucleolin, and YB-1. (a) Results of AptB1-AP/MS study revealed three candidate AptB1- interacting proteins: EAAT2, YB-1, and Nucleolin. (b) AP-immunoblots verified the interaction between AptB1 and EAAT2, Nucleolin, as well as YB-1 in the PC9 cells and in the mouse brain. (c) The confocal microscopy images showed colocalization (yellow) of AptB1 (red) and Nucleolin (green, upper panel) or YB-1 (green, lower panel) in the PC9 cells. (d) AptB1-treated cells were fractionated into cytosol and nucleus fractions. GAPDH is a cytosolic marker, and Histone H3 is a nucleus marker. The AptB1 sequences were successfully amplified in both cellular fractions. (e) The Coomassie Blue stain and the immunoblots showed the purified GST and GST-YB-1 proteins. (f) The YB-1 exonuclease assay results supported the role of YB-1 as an exonuclease for AptB1. (g) Scheme illustrating the proposed mechanism of AptBCis1 as therapeutics for lung cancer with and without LM.

    Article Snippet: Anti-luciferase antibody (sc-74548), EAAT2 siRNA (sc-35256), Nucleolin siRNA (sc-29230), YB-1 siRNA (sc38634), and GAPDH antibody (sc-32233) were purchased from Santa Cruz. γH2AX (9718), YB-1 (4202), and EAAT2 (20848) antibodies were purchased from Cell Signaling.

    Techniques: Protein-Protein interactions, Western Blot, Confocal Microscopy, Marker, Amplification, Staining, Purification

    Figure1. PrototypicalcharacteristicsofastrocytesexhibitedbyhumanPDAs.ExpressionofGFAPwasevaluatedbyWesternblot (a)andimmunofluorescence(b),EAAT2/GLT-1(c),andglutamatesynthetase(d)wasevaluatedinPDAsbyWesternblot.GAPDH wasusedasaloadingcontrol.Ine,glutamateuptakeinPDAswasmeasuredusingaglutamateassayfromBioVision(Milpitas,CA) with or without the addition of a GLT-1 inhibitor, DL-TBOA, at 100 M.

    Journal: Journal of Neuroscience

    Article Title: Human Immunodeficiency Virus Type 1 (HIV-1) Transactivator of Transcription through Its Intact Core and Cysteine-Rich Domains Inhibits Wnt/ -Catenin Signaling in Astrocytes: Relevance to HIV Neuropathogenesis

    doi: 10.1523/jneurosci.3145-12.2012

    Figure Lengend Snippet: Figure1. PrototypicalcharacteristicsofastrocytesexhibitedbyhumanPDAs.ExpressionofGFAPwasevaluatedbyWesternblot (a)andimmunofluorescence(b),EAAT2/GLT-1(c),andglutamatesynthetase(d)wasevaluatedinPDAsbyWesternblot.GAPDH wasusedasaloadingcontrol.Ine,glutamateuptakeinPDAswasmeasuredusingaglutamateassayfromBioVision(Milpitas,CA) with or without the addition of a GLT-1 inhibitor, DL-TBOA, at 100 M.

    Article Snippet: EAAT2/GLT-1 WB used a rabbit anti-human EAAT2 antibody from Cell Signaling.

    Techniques: